http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2011138101-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4858 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4891 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-12 |
| filingDate | 2010-03-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2013-04-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2011138101-A |
| titleOfInvention | PHARMACEUTICAL COMPOSITION MANIFESTING ANTI-INFLAMMATORY PROPERTIES |
| abstract | 1. A composition containing a sufficient amount of curcumin and a sufficient amount of emulsifier, where the specified composition is intended for use as a medicine, where a sufficient amount of curcumin is from 2 mg to 200 mg. The composition of claim 1, further encapsulated in a gelatin capsule. A composition according to any one of claims 1 or 2, further comprising an (organic) acid. 4. The composition according to claim 3, additionally containing from 3 wt.% To 30 wt.% An essential oil containing more than 50% terpene compounds. The composition according to claim 1, where the emulsifier has a viscosity at 25 ° C, a component of from 0.100 PA · s to 0.800 PA · s. The composition according to claim 5, where a sufficient amount of emulsifier is from 200 mg to 700 mg. The composition according to claim 1, where the emulsifier has a viscosity at 50 ° C, comprising from 75.0 PA · s to 175.0 PA · s. The composition according to claim 7, where a sufficient amount of emulsifier is from 100 mg to 700 mg. A composition according to any one of claims 7 or 8, further comprising a dehydrating agent selected from the group consisting of cellulose, cellulose derivatives and SiO.10. The composition according to claim 1 for use in the treatment and / or prevention of inflammation and / or diseases caused by inflammation. The composition of claim 10, wherein the disease due to inflammation is osteoarthritis (rheumatoid arthritis). A composition containing 10 mg to 100 mg of curcumin, 100 mg to 700 mg of emulsifier, acid, and additionally encapsulated in a gelatin capsule. 13. The composition of claim 12, comprising from 30 mg to 50 mg of curcumin and / or from 400 mg to 700 mg of emulsifier and / or from 1 mg to 5 mg of acid, preferably citric acid. |
| priorityDate | 2009-03-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 16.